Clinical benefits and safety of low-level LDL-C in the new era of lipid-lowering.
10.3760/cma.j.cn112148-20201019-00824
- Author:
Yong Jun LI
1
;
Gen Shan MA
1
Author Information
1. Department of Cardiology, Southeast University Affiliated Zhongda Hospital, Nanjing 210009, China.
- Publication Type:Journal Article
- MeSH:
Anticholesteremic Agents/therapeutic use*;
Cholesterol, LDL;
Humans;
Hydroxymethylglutaryl-CoA Reductase Inhibitors;
Hypolipidemic Agents/therapeutic use*;
Lipids
- From:
Chinese Journal of Cardiology
2021;49(6):548-553
- CountryChina
- Language:Chinese
